| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.14B | 2.18B | 2.24B | 2.58B | 1.62B |
| Gross Profit | 575.59M | 474.06M | 466.10M | 556.75M | 372.91M |
| EBITDA | 262.71M | 169.82M | 161.86M | 343.35M | 184.79M |
| Net Income | 95.61M | 46.48M | 36.05M | 128.67M | 103.14M |
Balance Sheet | |||||
| Total Assets | 1.88B | 1.40B | 1.23B | 1.43B | 1.11B |
| Cash, Cash Equivalents and Short-Term Investments | 17.83M | 33.74M | 13.00M | 65.07M | 7.76M |
| Total Debt | 788.09M | 623.07M | 564.03M | 789.86M | 570.59M |
| Total Liabilities | 963.58M | 763.08M | 705.25M | 922.00M | 700.89M |
| Stockholders Equity | 918.43M | 634.57M | 526.87M | 506.97M | 414.03M |
Cash Flow | |||||
| Free Cash Flow | 205.79M | 133.54M | 226.30M | 199.88M | -72.88M |
| Operating Cash Flow | 224.46M | 142.75M | 238.08M | 210.69M | -65.42M |
| Investing Cash Flow | -9.20M | -147.46M | -13.48M | -279.47M | -306.63M |
| Financing Cash Flow | -242.69M | 30.00M | -285.99M | 128.61M | 378.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$868.96M | 5.36 | 15.49% | 4.27% | 8.54% | 33.89% | |
66 Neutral | C$710.29M | 10.32 | 10.91% | 5.09% | 3.71% | -12.70% | |
65 Neutral | C$399.39M | 13.49 | 8.32% | ― | 2.99% | -12.14% | |
64 Neutral | C$861.68M | 8.76 | 11.37% | 1.74% | 7.18% | -9.38% | |
64 Neutral | C$866.22M | 10.20 | 12.47% | 5.85% | 28.20% | 36.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | C$2.62B | 14.57 | 10.04% | 3.88% | 8.15% | -3.57% |
ADENTRA reported full-year 2025 sales of US$2.25 billion, up 3% from 2024, driven partly by acquisition-based growth from Woolf Distributing and supported by resilient gross margins of 21.7%. Fourth-quarter sales edged down 2.5% to US$517.5 million, but Q4 gross margin improved to 22.1%, while basic earnings per share rose sharply to US$2.78 for the year and US$1.32 in the quarter.
Adjusted EBITDA increased to US$187.9 million for 2025, with an 8.4% margin, and strong operating cash flow of US$160.6 million enabled ADENTRA to cut its leverage ratio to 2.2x, repurchase 3.5% of its shares, and return US$29.5 million to shareholders via dividends and buybacks. Management highlighted disciplined execution and supply chain advantages in a muted housing market, while signaling cautious near-term outlook amid affordability and geopolitical headwinds but confidence in long-term growth supported by structural housing demand and favorable demographics.
The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$51.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.